4//SEC Filing
Mosseri Marlio Charles 4
Accession 0001104659-25-047938
CIK 0001875558other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:36 PM ET
Size
5.5 KB
Accession
0001104659-25-047938
Insider Transaction Report
Form 4
Mosseri Marlio Charles
10% Owner
Transactions
- Purchase
Common Stock
2025-05-12$8.11/sh+21,167$171,664→ 2,942,761 total(indirect: By Emerald Hill Ventures SARL SPF.)
Footnotes (2)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.11 to $8.12. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001806384
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 6:36 PM ET
- Size
- 5.5 KB